This suggests that the modulation of Shh expression in MCs might be a potential approach to generate therapies aimed at protecting neural circuits in epilepsy and excitotoxicity and treating cognitive and emotional disorders in which altered neurogenesis is a major component. Here, SHH is linked to epilepsy.